Arthur Tzianabos, Ph.D. President and Chief Executive Officer Arthur Tzianabos, Ph.D., brings 25 years of experience in the biotechnology industry leading teams in the discovery, development, clinical translation and commercialization of new treatments for rare diseases.
View Arthur Tzianabos’ profile on LinkedIn, the world's largest professional community. Arthur has 6 jobs listed on their profile. See the complete profile on LinkedIn and discover Arthur’s.
Arthur Tzianabos, Ph.D., BEDFORD, Mass.--(BUSINESS WIRE)-- Stoke Therapeutics, Inc., today announced that veteran biotech executive Arthur Tzianabos, Ph.D., who has extensive experience in the development and commercialization of rare disease treatments, will join the company’s board of directors.Tzianabos brings to OvaScience more than 20 years of experience in drug discovery and development, strategic planning, portfolio management, business development and alliance management.Thesis Titles. Jaufar, S. (2019) An archaeological study of the Maldive Islands: investigating the Islamic period settlements. Iuvaro, F. (2018) A study of William Crocker's photographic and film archive relating to the Canela Indians of Brazil.
The degree of Doctor of Philosophy is conferred by the Institute primarily in recognition of breadth of scholarship, depth of research, and the power to investigate problems independently and efficiently, rather than for the completion of definite courses of study through a stated period of residence.Read More
Dr Arthur Tzianabos, PhD - OvaScience. Dr. Tzianabos is President of OvaScience. Prior to this role, Dr. Tzianabos was Chief Scientific Officer at the Company. Dr. Tzianabos brings to OvaScience more than 20 years of experience in drug discovery and development, strategic planning, portfolio management, business development and alliance.Read More
Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get them in front of Issuu’s.Read More
A Thesis Submitted for the Degree of PhD at the University of Warwick. Arthur’s son, himself an alumnus of Emmanuel, who was the main beneficiary of. (1504-1575) and the English Reformation’ (PhD thesis, University of Birmingham, 2005). 3 specific context, can provide a necessary counterbalance to more wide-ranging or.Read More
Rick Arthur Bright (born June 7, 1966), is an American immunologist and public health official. Bright is the former director of the Biomedical Advanced Research and Development Authority (BARDA), leading the authority from 2016 to 2020. In May 2020, he filed a whistleblower complaint, alleging that his early warnings about the COVID-19 pandemic were ignored and that he was illegally.Read More
Arthur B. Laffer, PhD Share Arthur B. Laffer’s economic acumen and influence in triggering a world-wide tax-cutting movement in the 1980s have earned him the distinction in many publications as “The Father of Supply-Side Economics.”.Read More
Medieval Arthur (30 credits), exploring the Arthurian myth from the earliest archaeological evidence to the end of the fifteenth century, with a view to examining its evolution in a variety of the socio-political and cultural contexts, as well as material culture. Genres studied on this module will include historical documents, chronicles, romance, genealogy, written in Latin, Welsh, English.Read More
Doctoral thesis (PhD), Manchester Metropolitan University. Aboukanda, Entisar (2014) A study of human behaviour in Libyan healthcare. Doctoral thesis (PhD), Manchester Metropolitan University. Al Hakami, Husain (2014) Evaluation of setting a legal minimum age of marriage as a method of preventing zawaj al-gaserat in Saudi Arabia.Read More
A University of Sussex PhD thesis. Arthur Willemse Doctor of Philosophy School of History, Arts History and Philosophy University of Sussex July 2015. 2 Declaration I hereby declare that this thesis has not been submitted, either in the same or different form.Read More
SEP 18, 2018 - BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics today announced that Arthur Tzianabos, Ph.D., CEO and president of Homology Medicines, will join the company's board of directors.Read More